354 related articles for article (PubMed ID: 16019249)
21. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors.
Yinon Y; Beiner ME; Gotlieb WH; Korach Y; Perri T; Ben-Baruch G
Fertil Steril; 2007 Aug; 88(2):479-84. PubMed ID: 17408624
[TBL] [Abstract][Full Text] [Related]
22. Conservative surgery for borderline ovarian tumors: a review.
Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
[TBL] [Abstract][Full Text] [Related]
23. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
24. [Ovarian low malignant potential tumor: how to preserve fertility?].
Koskas M; Madelenat P; Yazbeck C
Gynecol Obstet Fertil; 2009; 37(11-12):942-50. PubMed ID: 19819742
[TBL] [Abstract][Full Text] [Related]
25. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer.
Borgfeldt C; Iosif C; Måsbäck A
Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):110-4. PubMed ID: 16859821
[TBL] [Abstract][Full Text] [Related]
26. Assisted reproductive technology and pregnancy outcome.
Shevell T; Malone FD; Vidaver J; Porter TF; Luthy DA; Comstock CH; Hankins GD; Eddleman K; Dolan S; Dugoff L; Craigo S; Timor IE; Carr SR; Wolfe HM; Bianchi DW; D'Alton ME
Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1039-45. PubMed ID: 16260523
[TBL] [Abstract][Full Text] [Related]
27. Infertility treatment after conservative management of borderline ovarian tumors.
Beiner ME; Gotlieb WH; Davidson B; Kopolovic J; Ben-Baruch G
Cancer; 2001 Jul; 92(2):320-5. PubMed ID: 11466685
[TBL] [Abstract][Full Text] [Related]
28. [Reproductive outcome after laparoscopic treatment of endometriosis in an infertile population].
Fuchs F; Raynal P; Salama S; Guillot E; Le Tohic A; Chis C; Panel P
J Gynecol Obstet Biol Reprod (Paris); 2007 Jun; 36(4):354-9. PubMed ID: 17399914
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother.
Romundstad LB; Romundstad PR; Sunde A; von Düring V; Skjaerven R; Vatten LJ
Hum Reprod; 2006 Sep; 21(9):2353-8. PubMed ID: 16728419
[TBL] [Abstract][Full Text] [Related]
30. The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation to limit the number of embryos transferred.
Dickey RP
Fertil Steril; 2007 Dec; 88(6):1554-61. PubMed ID: 17481621
[TBL] [Abstract][Full Text] [Related]
31. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
32. Borderline tumours of the ovary and fertility.
Morice P
Eur J Cancer; 2006 Jan; 42(2):149-58. PubMed ID: 16326097
[TBL] [Abstract][Full Text] [Related]
33. Conservatively treated borderline ovarian tumours, followed by IVF treatment: a case series.
Cabenda-Narain NE; Jansen FW; Dieben SW; Verburg HJ; Gaarenstroom KN
J Obstet Gynaecol; 2011 May; 31(4):327-9. PubMed ID: 21534756
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2008 Sep; 110(3):345-53. PubMed ID: 18586310
[TBL] [Abstract][Full Text] [Related]
35. Fertility sparing treatment of recurrent stage I serous borderline ovarian tumours.
Uzan C; Muller E; Kane A; Gouy S; Bendifallah S; Fauvet R; Darai E; Morice P
Hum Reprod; 2013 Dec; 28(12):3222-6. PubMed ID: 24067602
[TBL] [Abstract][Full Text] [Related]
36. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
[TBL] [Abstract][Full Text] [Related]
37. Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study.
Palomba S; Zupi E; Russo T; Falbo A; Del Negro S; Manguso F; Marconi D; Tolino A; Zullo F
Hum Reprod; 2007 Feb; 22(2):578-85. PubMed ID: 17050549
[TBL] [Abstract][Full Text] [Related]
38. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
39. A comparison of heterotopic and intrauterine-only pregnancy outcomes after assisted reproductive technologies in the United States from 1999 to 2002.
Clayton HB; Schieve LA; Peterson HB; Jamieson DJ; Reynolds MA; Wright VC
Fertil Steril; 2007 Feb; 87(2):303-9. PubMed ID: 17113092
[TBL] [Abstract][Full Text] [Related]
40. The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
Owj M; Tehrani-Nejad ES; Amirchaghmaghi E; Baghestani AR; Ahmadi J
Saudi Med J; 2005 Oct; 26(10):1584-7. PubMed ID: 16228060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
